Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$1.1bn reported value +18.6% vs Q1 2025
70positions
45.5%in top 10
18 new 24 added 16 reduced 24 sold out vs Q1 2025

Options: 2 call positions ($21.8m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 1,600,000 $161.0m15.04% 15.04% AddedShares held: Q3 2024 1.4m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m +50.0k +50,000 3.2%
2 BOSTON SCIENTIFIC CORP COM BSX BSX 550,000 $59.1m5.52% 5.52% ReducedShares held: Q3 2024 550.0k, Q4 2024 550.0k, Q1 2025 650.0k, Q2 2025 550.0k -100.0k -100,000 -15.4%
3 TENET HEALTHCARE CORP COM NEW THC THC 275,000 $48.4m4.52% 4.52% UnchangedShares held: Q3 2024 530.0k, Q4 2024 400.0k, Q1 2025 275.0k, Q2 2025 275.0k
4 ENCOMPASS HEALTH CORP COM EHC EHC 320,000 $39.2m3.67% 3.67% AddedShares held: Q3 2024 275.0k, Q4 2024 300.0k, Q1 2025 270.0k, Q2 2025 320.0k +50.0k +50,000 18.5%
5 MINERALYS THERAPEUTICS INC COM MLYS MLYS 2,700,000 $36.5m3.41% 3.41% AddedShares held: Q3 2024 356.0k, Q4 2024 875.0k, Q1 2025 2.3m, Q2 2025 2.7m +400.0k +400,000 17.4%
6 CYTOKINETICS INC COM NEW CYTK CYTK 1,000,000 $33.0m3.09% 3.09% ReducedShares held: Q3 2024 750.0k, Q4 2024 1.0m, Q1 2025 1.1m, Q2 2025 1.0m -100.0k -100,000 -9.1%
7 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 1,250,000 $29.5m2.75% 2.75% AddedShares held: Q3 2024 500.0k, Q4 2024 950.0k, Q1 2025 775.0k, Q2 2025 1.2m +475.0k +475,000 61.3%
8 VERA THERAPEUTICS INC CL A VERA VERA 1,150,000 $27.1m2.53% 2.53% UnchangedShares held: Q3 2024 500.0k, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
9 QUEST DIAGNOSTICS INC COM DGX DGX 150,000 $26.9m2.52% 2.52% NewShares held: Q3 2024 120.0k, Q4 2024 130.0k, Q1 2025 0, Q2 2025 150.0k
10 REGENERON PHARMACEUTICALS COM REGN REGN 50,000 $26.2m2.45% 2.45% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 50.0k
11 NOVARTIS AG SPONSORED ADR NVS NVS 200,000 $24.2m2.26% 2.26% ReducedShares held: Q3 2024 200.0k, Q4 2024 0, Q1 2025 250.0k, Q2 2025 200.0k -50.0k -50,000 -20.0%
12 CARDINAL HEALTH INC COM CAH CAH 140,000 $23.5m2.20% 2.20% NewShares held: Q3 2024 0, Q4 2024 250.0k, Q1 2025 0, Q2 2025 140.0k
13 ELEVANCE HEALTH INC COM ELV ELV 60,000 $23.3m2.18% 2.18% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 65.0k, Q2 2025 60.0k -5.0k -5,000 -7.7%
14 RADNET INC COM RDNT RDNT 400,000 $22.8m2.13% 2.13% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 250.0k, Q2 2025 400.0k +150.0k +150,000 60.0%
15 FRESENIUS MEDICAL CARE AG SPONSORED ADR FMS FMS 750,000 $21.4m2.00% 2.00% AddedShares held: Q3 2024 450.0k, Q4 2024 600.0k, Q1 2025 680.0k, Q2 2025 750.0k +70.0k +70,000 10.3%
16 ELI LILLY & CO COM LLY LLY 25,000 $19.5m1.82% 1.82% NewShares held: Q3 2024 10.0k, Q4 2024 38.0k, Q1 2025 0, Q2 2025 25.0k
17 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 150,000 $18.9m1.76% 1.76% UnchangedShares held: Q3 2024 0, Q4 2024 160.0k, Q1 2025 150.0k, Q2 2025 150.0k
18 UNIQURE NV SHS QURE QURE 1,350,000 $18.8m1.76% 1.76% AddedShares held: Q3 2024 400.0k, Q4 2024 1.1m, Q1 2025 1.2m, Q2 2025 1.4m +100.0k +100,000 8.0%
19 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 55,000 $17.9m1.68% 1.68% AddedShares held: Q3 2024 25.0k, Q4 2024 45.0k, Q1 2025 50.0k, Q2 2025 55.0k +5.0k +5,000 10.0%
20 DEXCOM INC COM DXCM DXCM 200,000 $17.5m1.63% 1.63% AddedShares held: Q3 2024 120.0k, Q4 2024 150.0k, Q1 2025 100.0k, Q2 2025 200.0k +100.0k +100,000 100.0%
21 CHARLES RIV LABS INTL INC COM CRL CRL 115,000 $17.4m1.63% 1.63% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 115.0k
22 MEDTRONIC PLC SHS MDT MDT 200,000 $17.4m1.63% 1.63% ReducedShares held: Q3 2024 300.0k, Q4 2024 150.0k, Q1 2025 300.0k, Q2 2025 200.0k -100.0k -100,000 -33.3%
23 CVS HEALTH CORP COM CVS CVS 250,000 $17.2m1.61% 1.61% AddedShares held: Q3 2024 0, Q4 2024 500.0k, Q1 2025 200.0k, Q2 2025 250.0k +50.0k +50,000 25.0%
24 PFIZER INC COM PFE PFE 700,000 $17.0m1.59% 1.59% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 300.0k, Q2 2025 700.0k +400.0k +400,000 133.3%
25 EDWARDS LIFESCIENCES CORP COM EW EW 200,000 $15.6m1.46% 1.46% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 125.0k, Q2 2025 200.0k +75.0k +75,000 60.0%
26 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 200,000 $14.8m1.38% 1.38% AddedShares held: Q3 2024 20.0k, Q4 2024 0, Q1 2025 150.0k, Q2 2025 200.0k +50.0k +50,000 33.3%
27 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 200,000 $14.0m1.31% 1.31% NewShares held: Q3 2024 0, Q4 2024 225.0k, Q1 2025 0, Q2 2025 200.0k
28 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,000,000 $13.1m1.22% 1.22% AddedShares held: Q3 2024 0, Q4 2024 550.0k, Q1 2025 675.0k, Q2 2025 1.0m +325.0k +325,000 48.1%
29 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,250,000 $12.7m1.19% 1.19% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.2m
30 REVOLUTION MEDICINES INC COM RVMD RVMD 325,000 $12.0m1.12% 1.12% AddedShares held: Q3 2024 350.0k, Q4 2024 550.0k, Q1 2025 250.0k, Q2 2025 325.0k +75.0k +75,000 30.0%
31 89BIO INC COM ETNB ETNB 1,050,000 $10.3m0.96% 0.96% UnchangedShares held: Q3 2024 500.0k, Q4 2024 1.0m, Q1 2025 1.1m, Q2 2025 1.1m
32 PENUMBRA INC COM PEN PEN 40,000 $10.3m0.96% 0.96% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 35.0k, Q2 2025 40.0k +5.0k +5,000 14.3%
33 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 200,000 $9.4m0.88% 0.88% UnchangedShares held: Q3 2024 220.0k, Q4 2024 200.0k, Q1 2025 200.0k, Q2 2025 200.0k
34 INSPIRE MED SYS INC COM INSP INSP 70,000 $9.1m0.85% 0.85% AddedShares held: Q3 2024 160.0k, Q4 2024 100.0k, Q1 2025 65.0k, Q2 2025 70.0k +5.0k +5,000 7.7%
35 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 400,000 $9.1m0.85% 0.85% AddedShares held: Q3 2024 0, Q4 2024 300.0k, Q1 2025 250.0k, Q2 2025 400.0k +150.0k +150,000 60.0%
36 BEAM THERAPEUTICS INC COM BEAM BEAM 500,000 $8.5m0.79% 0.79% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 500.0k
37 HOLOGIC INC COM HOLX HOLX 125,000 $8.1m0.76% 0.76% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 125.0k
38 TARSUS PHARMACEUTICALS INC COM TARS TARS 200,000 $8.1m0.76% 0.76% UnchangedShares held: Q3 2024 375.0k, Q4 2024 350.0k, Q1 2025 200.0k, Q2 2025 200.0k
39 REZOLUTE INC COM NEW RZLT RZLT 1,800,000 $8.0m0.75% 0.75% AddedShares held: Q3 2024 250.0k, Q4 2024 500.0k, Q1 2025 500.0k, Q2 2025 1.8m +1.3m +1,300,000 260.0%
40 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 120,000 $7.6m0.71% 0.71% NewShares held: Q3 2024 0, Q4 2024 150.0k, Q1 2025 0, Q2 2025 120.0k
41 BAXTER INTL INC COM BAX BAX 250,000 $7.6m0.71% 0.71% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 500.0k, Q2 2025 250.0k -250.0k -250,000 -50.0%
42 ABBVIE INC COM ABBV ABBV 40,000 $7.4m0.69% 0.69% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 60.0k, Q2 2025 40.0k -20.0k -20,000 -33.3%
43 MCKESSON CORP COM MCK MCK 10,000 $7.3m0.68% 0.68% ReducedShares held: Q3 2024 0, Q4 2024 35.0k, Q1 2025 12.0k, Q2 2025 10.0k -2.0k -2,000 -16.7%
44 ROIVANT SCIENCES LTD SHS ROIV ROIV 600,000 $6.8m0.63% 0.63% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 600.0k, Q2 2025 600.0k
45 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 40,000 $6.2m0.58% 0.58% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 40.0k
46 AGILENT TECHNOLOGIES INC COM A A 50,000 $5.9m0.55% 0.55% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 50.0k
47 REGENXBIO INC COM RGNX RGNX 700,000 $5.7m0.54% 0.54% ReducedShares held: Q3 2024 1.3m, Q4 2024 900.0k, Q1 2025 925.0k, Q2 2025 700.0k -225.0k -225,000 -24.3%
48 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 60,000 $5.7m0.53% 0.53% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 115.0k, Q2 2025 60.0k -55.0k -55,000 -47.8%
49 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 400,000 $5.6m0.52% 0.52% AddedShares held: Q3 2024 0, Q4 2024 500.0k, Q1 2025 200.0k, Q2 2025 400.0k +200.0k +200,000 100.0%
50 ATYR PHARMA INC COM NEW ATYR ATYR 1,050,000 $5.3m0.50% 0.50% AddedShares held: Q3 2024 0, Q4 2024 375.0k, Q1 2025 700.0k, Q2 2025 1.1m +350.0k +350,000 50.0%
51 EXACT SCIENCES CORP COM EXAS EXAS 100,000 $5.3m0.50% 0.50% NewShares held: Q3 2024 80.0k, Q4 2024 150.0k, Q1 2025 0, Q2 2025 100.0k
52 WATERS CORP COM WAT WAT 15,000 $5.2m0.49% 0.49% ReducedShares held: Q3 2024 0, Q4 2024 30.0k, Q1 2025 20.0k, Q2 2025 15.0k -5.0k -5,000 -25.0%
53 GLAUKOS CORP COM GKOS GKOS 50,000 $5.2m0.48% 0.48% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 50.0k
54 ELANCO ANIMAL HEALTH INC COM ELAN ELAN 350,000 $5.0m0.47% 0.47% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 350.0k
55 COOPER COS INC COM COO COO 70,000 $5.0m0.47% 0.47% NewShares held: Q3 2024 110.0k, Q4 2024 100.0k, Q1 2025 0, Q2 2025 70.0k
56 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 100,000 $4.9m0.45% 0.45% ReducedShares held: Q3 2024 150.0k, Q4 2024 0, Q1 2025 150.0k, Q2 2025 100.0k -50.0k -50,000 -33.3%
57 PROTARA THERAPEUTICS INC COM STK TARA TARA 1,400,000 $4.2m0.40% 0.40% UnchangedShares held: Q3 2024 0, Q4 2024 1.4m, Q1 2025 1.4m, Q2 2025 1.4m
58 BIOHAVEN LTD COM BHVN BHVN 300,000 $4.2m0.40% 0.40% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 175.0k, Q2 2025 300.0k +125.0k +125,000 71.4%
59 SANA BIOTECHNOLOGY INC COM SANA SANA 1,500,000 $4.1m0.38% 0.38% ReducedShares held: Q3 2024 1.8m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 1.5m -500.0k -500,000 -25.0%
60 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 100,000 $3.6m0.34% 0.34% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 100.0k
61 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 100,000 $3.5m0.33% 0.33% ReducedShares held: Q3 2024 275.0k, Q4 2024 375.0k, Q1 2025 125.0k, Q2 2025 100.0k -25.0k -25,000 -20.0%
62 NURIX THERAPEUTICS INC COM NRIX NRIX 310,000 $3.5m0.33% 0.33% AddedShares held: Q3 2024 200.0k, Q4 2024 250.0k, Q1 2025 275.0k, Q2 2025 310.0k +35.0k +35,000 12.7%
63 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 590,000 $3.3m0.31% 0.31% AddedShares held: Q3 2024 350.0k, Q4 2024 650.0k, Q1 2025 575.0k, Q2 2025 590.0k +15.0k +15,000 2.6%
64 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 150,000 $3.3m0.30% 0.30% UnchangedShares held: Q3 2024 400.0k, Q4 2024 300.0k, Q1 2025 150.0k, Q2 2025 150.0k
65 ALKERMES PLC SHS ALKS ALKS 100,000 $2.9m0.27% 0.27% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 150.0k, Q2 2025 100.0k -50.0k -50,000 -33.3%
66 TERNS PHARMACEUTICALS INC COM COM 700,000 $2.6m0.24% 0.24% UnchangedShares held: Q3 2024 300.0k, Q4 2024 450.0k, Q1 2025 700.0k, Q2 2025 700.0k
67 ARCUS BIOSCIENCES INC COM RCUS RCUS 300,000 $2.4m0.23% 0.23% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 300.0k
68 OSCAR HEALTH INC CL A OSCR OSCR 100,000 $2.1m0.20% 0.20% ReducedShares held: Q3 2024 0, Q4 2024 700.0k, Q1 2025 200.0k, Q2 2025 100.0k -100.0k -100,000 -50.0%
69 TENAX THERAPEUTICS INC COM NEW TENX TENX 167,000 $961.9k0.09% 0.09% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 167.0k, Q2 2025 167.0k
70 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 400,000 $880.0k0.08% 0.08% UnchangedShares held: Q3 2024 0, Q4 2024 300.0k, Q1 2025 400.0k, Q2 2025 400.0k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
GILEAD SCIENCES INC GILD GILD 175,000 $19.6m175.0k shares
ASCENDIS PHARMA A/S 100,000 $15.6m100.0k shares
BLUEPRINT MEDICINES CORP BPMC BPMC 145,000 $12.8m145.0k shares
KRYSTAL BIOTECH INC KRYS KRYS 60,000 $10.8m60.0k shares
TEVA PHARMACEUTICAL INDS LTD 500,000 $7.7m500.0k shares
MASIMO CORP MASI MASI 45,000 $7.5m45.0k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 100,000 $6.1m100.0k shares
IQVIA HLDGS INC IQV IQV 30,000 $5.3m30.0k shares
PTC THERAPEUTICS INC PTCT PTCT 100,000 $5.1m100.0k shares
DYNE THERAPEUTICS INC DYN DYN 450,000 $4.7m450.0k shares
LABCORP HOLDINGS INC LH LH 20,000 $4.7m20.0k shares
BECTON DICKINSON & CO BDX BDX 20,000 $4.6m20.0k shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 125,000 $4.2m125.0k shares
GLOBUS MED INC GMED GMED 50,000 $3.7m50.0k shares
BIONTECH SE BNTX BNTX 40,000 $3.6m40.0k shares
BRIDGEBIO PHARMA INC BBIO BBIO 100,000 $3.5m100.0k shares
THE CIGNA GROUP CI CI 10,000 $3.3m10.0k shares
VERASTEM INC VSTM VSTM 500,000 $3.0m500.0k shares
REPLIGEN CORP RGEN RGEN 20,000 $2.5m20.0k shares
ARROWHEAD PHARMACEUTICALS IN ARWR ARWR 175,000 $2.2m175.0k shares
MEREO BIOPHARMA GROUP PLC MREO MREO 800,000 $1.8m800.0k shares
CABALETTA BIO INC CABA CABA 850,000 $1.2m850.0k shares
PALATIN TECHNOLOGIES INC 1,000,000 $582.9k1.0m shares
FATE THERAPEUTICS INC FATE FATE 700,000 $553.1k700.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
CYTOKINETICS INC CYTK · Call CYTKCall 500,000 $16.5m500.0k shares New
VIKING THERAPEUTICS INC VKTX · Call VKTXCall 200,000 $5.3m200.0k shares Unchanged